1. Home
  2. SPCB vs INTS Comparison

SPCB vs INTS Comparison

Compare SPCB & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

N/A

Current Price

$9.03

Market Cap

45.3M

Sector

Technology

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
INTS
Founded
1988
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.3M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SPCB
INTS
Price
$9.03
$0.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$18.00
$4.33
AVG Volume (30 Days)
39.4K
3.2M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.13
N/A
P/E Ratio
$10.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$0.19
52 Week High
$18.95
$3.17

Technical Indicators

Market Signals
Indicator
SPCB
INTS
Relative Strength Index (RSI) 44.73 47.41
Support Level $8.98 $0.35
Resistance Level $9.45 $0.43
Average True Range (ATR) 0.44 0.05
MACD 0.01 -0.01
Stochastic Oscillator 28.91 21.28

Price Performance

Historical Comparison
SPCB
INTS

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: